Kazuhiro Namura

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer.

A higher De Ritis ratio (AST/ALT) is a risk factor for progression in high-risk non-muscle invasive bladder cancer.

Journal: Oncotarget

Published: October 26, 2020

Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report.

Primary amelanotic malignant melanoma of the male urethra with inguinal lymph node metastasis successfully controlled by nivolumab: A case report.

Journal: Urology case reports

Published: February 27, 2018

A CASE OF TEMPORARY CARDIAC ARREST FOLLOWING SUDDEN FLUCTUATION OF BLOOD PRESSURE AFTER INITIATION OF PNEUMOPERITONEUM IN LAPAROSCOPIC ADRENALECTOMY FOR ADRENAL PHEOCHROMOCYTOMA

A CASE OF TEMPORARY CARDIAC ARREST FOLLOWING SUDDEN FLUCTUATION OF BLOOD PRESSURE AFTER INITIATION OF PNEUMOPERITONEUM IN LAPAROSCOPIC ADRENALECTOMY FOR ADRENAL PHEOCHROMOCYTOMA

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: January 01, 2018

Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.

Time-dependent change in relapse sites of renal cell carcinoma after curative surgery.

Journal: Clinical & experimental metastasis

Published: November 08, 2017

FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.

FDG PET/CT after first molecular targeted therapy predicts survival of patients with renal cell carcinoma.

Journal: Cancer chemotherapy and pharmacology

Published: August 12, 2017

A Case of Squamous Cell Carcinoma in Bladder Diverticulum Producing Granulocyte Colony Stimulating Factor

A Case of Squamous Cell Carcinoma in Bladder Diverticulum Producing Granulocyte Colony Stimulating Factor

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: June 19, 2017

One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.

One-month assessment of renal cell carcinoma treated by everolimus using FDG PET/CT predicts progression-free and overall survival.

Journal: Cancer chemotherapy and pharmacology

Published: January 01, 2017

Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.

Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study.

Journal: Abdominal radiology (New York)

Published: April 04, 2016

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.

The acceleration of glucose accumulation in renal cell carcinoma assessed by FDG PET/CT demonstrated acquisition of resistance to tyrosine kinase inhibitor therapy.

Journal: BMC cancer

Published: November 24, 2015

A Case of Abdominal Wall Desmoid Tumor after Radical Nephrectomy for Renal Cancer

A Case of Abdominal Wall Desmoid Tumor after Radical Nephrectomy for Renal Cancer

Journal: Hinyokika kiyo. Acta urologica Japonica

Published: October 27, 2015

PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB

PATHOLOGICAL COMPLETE RESPONSE WITH EVEROLIMUS FOR MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA RESISTANT TO SUNITINIB

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: September 25, 2015

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.

FDG PET/CT as a prognostic biomarker in the era of molecular-targeting therapies: max SUVmax predicts survival of patients with advanced renal cell carcinoma.

Journal: BMC cancer

Published: February 15, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026